MPT Resource Center

Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study

Evofem Biosciences completes phase 2b ‘AMPREVENCE’ trial of Amphora for prevention of chlamydia and gonorrhea in women

Evofem Biosciences announces last patient enrolled for AMPREVENCE, the phase 2b sexually transmitted infections trial of Amphora

Daré Bioscience completes recruitment in pre-pivotal trial of monthly woman-controlled, hormone-free contraceptive candidate, Ovaprene®

Evofem Biosciences enters into financing agreement for up to $80 million, closes first tranche of strategic investment from PDL BioPharma

Evofem Biosciences reports fourth quarter and year-end 2018 financial results and provides corporate update

Researchers at Queen’s University Belfast have developed a vaginal ring capable of providing sustained delivery of OB-002 (5P12-RANTES) for HIV prevention

MTN researchers begin safety study of a 90-day vaginal ring containing tenofovir

Evofem Biosciences announces positive top-line results of phase 3 study evaluating Amphora for hormone-free birth control

CIFF announces over $15 million in funding for contraception access and innovation

Population Council to determine feasibility of fast-tracking oral contraceptive multipurpose prevention technology (cMPT) development

Antibody-based contraceptive research center awarded to Boston University led consortium

Rise in prevalence of STDs reported by CDC supports continued development of novel solutions, like Evofem’s product in development, Amphora, for the prevention of chlamydia

Evofem Biosciences’ Chief Medical Officer, Dr. Kelly Culwell, to present at #BlogHer18 Creators Summit

First multipurpose gel designed to prevent HIV, HSV, and HPV simultaneously in women and men advances in clinical trials

Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia

Evofem Biosciences announces first patient enrolled in phase 2b/3 STI trial of Amphora ® and expects phase 3 contraceptive clinical trial data first quarter 2019

Declining Funding and Shrinking Donor Base Imperils Continued Success of HIV Prevention Research; European Countries Called to Renew Support

Declining Funding and Shrinking Donor Base Imperils Continued Success of HIV Prevention Research; European Countries Called to Renew Support 10 July 2017 click to view Press Release In this Press Release: Health Risk(s): HIV Topic(s): Funding

International Partnership for Microbicides Appoints Three Members to Its Board of Directors

International Partnership for Microbicides Appoints Three Members to Its Board of Directors 06 July 2017 click to view Press Release In this Press Release:

IPM Advances Three-month HIV Prevention and Contraception Ring to Clinical Trial

IPM Advances Three-month HIV Prevention and Contraception Ring to Clinical Trial 03 May 2017 click to view Press Release In this Press Release: Health Risk(s): HIV Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): MPTs Product Development Reproductive Health

WomanCare Global Launches Improved Woman’s Condom in Zambia

WomanCare Global Launches Improved Woman’s Condom in Zambia 22 March 2016 click to view Press Release In this Press Release: Health Risk(s): Unintended Pregnancy Product Type(s): Condoms Topic(s): Product Introduction / Uptake

SRI Awarded $150 Million NIAID-DAIDS Contract to Provide Development and Manufacturing Support for Promising HIV-Prevention Products

SRI Awarded $150 Million NIAID-DAIDS Contract to Provide Development and Manufacturing Support for Promising HIV-Prevention Products 06 December 2016 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): MPTs Topic(s): Product Development

Growing Popularity of Female Condoms is one of the Driving Factors of Global Condom Market

Growing Popularity of Female Condoms is one of the Driving Factors of Global Condom Market 01 November 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Topic(s): Product Introduction / Uptake

Advancing Better Women’s Health Prevention: The IMPT Receives $4.49 Million U.S. Government Award to support MPTs

Advancing Better Women’s Health Prevention: The IMPT Receives $4.49 Million U.S. Government Award to support MPTs 01 August 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Funding MPTs

The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support

The Division of AIDS Awards ABL a Seven-Year Contract to Provide HIV Microbicide Research and Product Development Support 26 July 2016 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): Microbicides Topic(s): Funding

CONRAD launches Quatro in South Africa and Zimbabwe

CONRAD launches Quatro in South Africa and Zimbabwe 05 July 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Product Type(s): IVR (Intravaginal Rings) Microbicides Vaginal Cream/Gel Other or N/A Topic(s): Reproductive Health Social/Behavioral Context

Brazilian Ministry of Health to Distribute 100,000 FC2s from The Female Health Company at the 2016 Summer Olympics in Rio de Janeiro

Brazilian Ministry of Health to Distribute 100,000 FC2s from The Female Health Company at the 2016 Summer Olympics in Rio de Janeiro 26 May 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms

The Female Health Company Donates Female Condoms, to Work with CDC on Education and Training, as Part of STD Awareness Month

The Female Health Company Donates Female Condoms, to Work with CDC on Education and Training, as Part of STD Awareness Month 09 May 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Topic(s): Advocacy Education

New Vaginal Ring Can Reduce Women’s HIV Rates & Will Next Combine With Contraception As An MPT (Multipurpose Prevention Technology)

New Vaginal Ring Can Reduce Women’s HIV Rates & Will Next Combine With Contraception As An MPT (Multipurpose Prevention Technology) 22 February 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives IVR (Intravaginal Rings) MPTs Topic(s): MPTs Product Development Product Trials Reproductive Health

Clinical Trials Begin on Antibody-based Prevention of HIV and Genital Herpes: Leaf Bio’s MB66 Developed as Multipurpose Prevention Technology

Clinical Trials Begin on Antibody-based Prevention of HIV and Genital Herpes: Leaf Bio’s MB66 Developed as Multipurpose Prevention Technology 07 January 2016 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Product Type(s): MPTs Topic(s): MPTs Product Development Product Trials Reproductive Health

WomanCare Global Announces Launch of Whisper Woman’s Condom in Malawi

WomanCare Global Announces Launch of Whisper Woman’s Condom in Malawi 06 January 2016 click to view Press Release In this Press Release: Health Risk(s): Unintended Pregnancy Product Type(s): Condoms Topic(s): Product Introduction / Uptake

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention 01 December 2015 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): Microbicides Topic(s): Product Development

Population Council’s MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study

Population Council’s MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study 24 November 2015 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): Microbicides Vaginal Cream/Gel Topic(s): Product Trials

IPM Initiates First Trial of Novel HIV Prevention Drug for Women

IPM Initiates First Trial of Novel HIV Prevention Drug for Women 03 November 2015 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): ARVs Other or N/A Topic(s): Product Development Product Trials

New Generation of Women’s Health Tools on Horizon: Simultaneous Prevention of HIV, other STIs and Unplanned Pregnancy with MPTs

New Generation of Women’s Health Tools on Horizon: Simultaneous Prevention of HIV, other STIs and Unplanned Pregnancy with MPTs 11 September 2015 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): MPTs

Investment in post-efficacy R&D critical for PrEP, other new HIV prevention options

Investment in post-efficacy R&D critical for PrEP, other new HIV prevention options 17 July 2015 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): Other or N/A Topic(s): Advocacy Funding

Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC

Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC 02 April 2015 click to view Press Release In this Press Release: Health Risk(s): Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) Topic(s): Product Development

Evofem Holdings, Inc. Announces Successful Completion of Pre-IND Meeting for Amphora

Evofem Holdings, Inc. Announces Successful Completion of Pre-IND Meeting for Amphora 11 January 2015 click to view Press Release In this Press Release: Health Risk(s): Bacterial Vaginosis Product Type(s): Contraceptives Vaginal Cream/Gel Topic(s): Product Development Product Trials Reproductive Health

CONRAD Launches First-Ever Multipurpose Vaginal Ring Clinical Trial

CONRAD Launches First-Ever Multipurpose Vaginal Ring Clinical Trial 17 November 2014 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) Topic(s): Product Trials

Population Council Launches Phase 1 Clinical Trial of a Novel Microbicide Gel to Prevent HIV and Other STIs

Population Council Launches Phase 1 Clinical Trial of a Novel Microbicide Gel to Prevent HIV and Other STIs 29 September 2014 click to view Press Release In this Press Release: Health Risk(s): HIV STI / STD Product Type(s): Microbicides Topic(s): Product Development

Regulatory clearance opens the way for new single-size contraceptive diaphragm in the United States

Regulatory clearance opens the way for new single-size contraceptive diaphragm in the United States 09 September 2014 click to view Press Release In this Press Release: Health Risk(s): Unintended Pregnancy Product Type(s): Diaphragm Topic(s): Product Development

IPM receives worldwide rights to HIV prevention

IPM receives worldwide rights to HIV prevention 08 May 2014 click to view Press Release In this Press Release: Health Risk(s): HIV Product Type(s): Microbicides Topic(s): Product Development